KLRK1 and cancer: CD24 blocker promotes cancer cell phagocytosis; Inhibits cancer cell metastasis, progression and chemo-resistance by inhibiting β1 integrin stability; Promotes NK cell and CD8+ T cell-mediated killing of cancer cells via NKG2D